KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $70,200 | -37.3% | 20,647 | 0.0% | 0.00% | – |
| Q3 2022 | $112,000 | -50.7% | 20,647 | -46.9% | 0.00% | – |
| Q1 2019 | $227,000 | -98.7% | 38,861 | -97.8% | 0.00% | -100.0% |
| Q4 2018 | $16,864,000 | -46.2% | 1,799,696 | -2.2% | 0.01% | -37.5% |
| Q3 2018 | $31,335,000 | -12.3% | 1,840,013 | -12.5% | 0.02% | -11.1% |
| Q2 2018 | $35,734,000 | +29.8% | 2,103,256 | +2.5% | 0.02% | +28.6% |
| Q1 2018 | $27,538,000 | -14.1% | 2,051,984 | -38.5% | 0.01% | -6.7% |
| Q4 2017 | $32,041,000 | -7.0% | 3,337,569 | +6.4% | 0.02% | -11.8% |
| Q3 2017 | $34,447,000 | +22.7% | 3,137,259 | +1.1% | 0.02% | +21.4% |
| Q2 2017 | $28,076,000 | -30.5% | 3,102,336 | -1.5% | 0.01% | -33.3% |
| Q1 2017 | $40,424,000 | +33.1% | 3,148,278 | -2.6% | 0.02% | +31.2% |
| Q4 2016 | $30,374,000 | -4.7% | 3,231,201 | -1.4% | 0.02% | -5.9% |
| Q3 2016 | $31,887,000 | +45.0% | 3,277,209 | -0.0% | 0.02% | +41.7% |
| Q2 2016 | $21,996,000 | -42.4% | 3,278,123 | -23.5% | 0.01% | -40.0% |
| Q1 2016 | $38,215,000 | -44.2% | 4,284,188 | -17.1% | 0.02% | -42.9% |
| Q4 2015 | $68,490,000 | +15.8% | 5,168,970 | -7.9% | 0.04% | +20.7% |
| Q3 2015 | $59,124,000 | -53.8% | 5,614,726 | +19.3% | 0.03% | -50.0% |
| Q2 2015 | $128,107,000 | -13.7% | 4,708,087 | -2.9% | 0.06% | -13.4% |
| Q1 2015 | $148,434,000 | -14.8% | 4,849,252 | +4.2% | 0.07% | -15.2% |
| Q4 2014 | $174,154,000 | +12.8% | 4,652,759 | +5.3% | 0.08% | +12.9% |
| Q3 2014 | $154,433,000 | -21.8% | 4,420,010 | +4.2% | 0.07% | -19.5% |
| Q2 2014 | $197,505,000 | +218.4% | 4,242,943 | +111.3% | 0.09% | +200.0% |
| Q1 2014 | $62,031,000 | +243.9% | 2,008,114 | +155.2% | 0.03% | +222.2% |
| Q4 2013 | $18,036,000 | – | 786,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |